Brief: Prescient Therapeutics Announces Strategic Collaboration With MD Anderson Cancer Center
06/09/2022 23:48
Sept 7 (Reuters) - Prescient Therapeutics Ltd PTX.AX :
* PTX STRATEGIC COLLABORATION WITH MD ANDERSON CANCER
CENTER-PTX.AX
* COLLABORATION TO CREATE ADAPTABLE CAR-T CELL THERAPIES TO
TREAT
HEMATOLOGICAL MALIGNANCIES
Source text for Eikon: ID:nASX3vm83w
Further company coverage: PTX.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Prescient Therapeutics
See all newsAustralia's Prescient Therapeutics falls on discounted share placement
Brief: Prescient Therapeutics Raises A$4.8 Million Via SPP, A$1.2 Million In Placement
Brief: Prescient Therapeutics Says Trading Halt Requested
Australia's Prescient Therapeutics hits near 2-month low on discounted raise
Brief: Prescient Therapeutics Secures EU Authorisation To Commence PTX-100 Clinical Trial